MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

49.27 -0.59 (-1.18%)
Official Closing Price Updated: 7:00 PM EDT, Aug 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,376,625
Open 49.64
Bid (Size) 49.21 (5)
Ask (Size) 49.25 (6)
Prev. Close 49.86
Today's Range 49.06 - 49.97
52wk Range 40.94 - 61.71
Shares Outstanding 5,606,688,356
Dividend Yield 3.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Disney Leads Media Earnings This Week As Reporting Season Moves Past The Peak
We are past the peak of earnings season, and about 87% of the S&P 500 companies have already released their quarterly numbers, FactSet reports. 
Via Benzinga
3 Blue-Chip Stocks With Rock-Solid Dividends
Investing in blue-chip stocks is a stellar strategy. Blue-chip stocks are companies that have consistently provided quality, reliability, and the ability to operate profitably in good and bad times.... 
Via Talk Markets

Performance

YTD
-13.03%
-13.03%
1 Month
-7.33%
-7.33%
3 Month
+1.30%
+1.30%
6 Month
-7.40%
-7.40%
1 Year
+7.16%
+7.16%

More News

Read More
Small Cap Biotechs Perk Up On Dealmaking
Via Talk Markets
Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion
Via Investor's Business Daily
Pfizer Cuts Late-Stage Asset For Rare Cardiovascular Acquired Via $11.4B Array acquisition
Via Benzinga
Are You at Increased Risk of Getting Pneumococcal Pneumonia?
Via StatePoint Media
Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report
Via Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
Via Benzinga
Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024
Via Benzinga
Alnylam's Hot Streak Cools As Expert Questions Uptake For Its Heart Drug
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Death Cross Looms Over Pfizer Investors
Via Benzinga
CBOE's Weekly Market Recap: July 18 To 22
Via Benzinga
3 Pharma Stocks' Post-Earnings Price Moves
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
Omicron BA.4/5 Subvariants Are More Contagious And More Treatment-Resistant, But This Biopharma Reports Working On A Potential Breakthrough
Via Benzinga
Alnylam Pharmaceuticals Is On Track To Hit A Record High — Here's Why
Via Investor's Business Daily
Don’t Mess With The IRS
Via Talk Markets
3 Health Care Stocks in Great Financial Health
Via MarketBeat
Chevron To $185? Plus Stephens Predicts $800 For This Stock
Via Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Via Benzinga
Biden Tests Positive For COVID For The Second Time In 2022
Via Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Mark Cuban Says Americans Shouldn't Have To Pick Between Rent, Food Or Medicine
Via Benzinga
Expert Ratings for Pfizer
Via Benzinga
Stock Market Rally Powers Higher On Fed Rate Hints; Apple, Microsoft, Meta, Amazon, Google Key Earnings: Weekly Review
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story